Increased circulating VCAM-1 correlates with advanced disease and poor survival in patients with multiple myeloma: reduction by post-bortezomib and lenalidomide treatment

Circulating vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and selectins were prospectively measured in 145 newly-diagnosed patients with symptomatic myeloma (NDMM), 61 patients with asymptomatic/smoldering myeloma (SMM), 47 with monoclonal gammopathy of undet...

Descripción completa

Detalles Bibliográficos
Autores principales: Terpos, E, Migkou, M, Christoulas, D, Gavriatopoulou, M, Eleutherakis-Papaiakovou, E, Kanellias, N, Iakovaki, M, Panagiotidis, I, Ziogas, D C, Fotiou, D, Kastritis, E, Dimopoulos, M A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916305/
https://www.ncbi.nlm.nih.gov/pubmed/27232930
http://dx.doi.org/10.1038/bcj.2016.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916305/
https://www.ncbi.nlm.nih.gov/pubmed/27232930
http://dx.doi.org/10.1038/bcj.2016.37

Ejemplares similares